Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Orgenesis
Orgenesis
Activities:
Research & Development
Pharmaceutical
Cell & Gene Therapy
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
Orgenesis and Theracell collaboration designated priority investment in Greece
As a result of this designation, the venture will be inducted into the country’s fast-track licensing and approval process
Research & Development
Orgenesis announces collaboration with Tel Aviv Medical Center
The collaboration aims to advance point-of-care development and commercialisation of cell and gene and therapies
Finance
Orgenesis to collaborate with Savicell on ImmunoBiopsy platform
The collaboration aims to develop and validate diagnostic kits for enhanced quality control (QC) and monitoring purposes to be used by Orgenesis for CGT applications
Research & Development
Orgenesis to trial Tissue Genesis Icellator tech for cell recovery
The trial is supported by the National Stem Cell Foundation and an OREF clinical research grant in cellular therapy in honour of James Urbaniak, MD
Drug Delivery
Orgenesis signs joint venture with Cure Therapeutics
The agreement aims to to advance point-of-care development and commercialisation of cell and gene therapies
Pharmaceutical
Orgenesis launches cell-based vaccine platform targeting SARS-CoV-2
US biotech has created a cell-based vaccine platform targeting solid tumours for use against viral diseases
Finance
Orgenesis acquires cell therapy manufacturer MaSTherCell
Acquisition to accelerate type 1 diabetes therapeutic into clinical trials and diversify future business model and product offering
Subscribe now